Several models for prognostic stratification of patients with metastatic renal-cell carcinoma have been reported. The two most widely used models are the Memorial Sloan Kettering Cancer Center (MSKCC) and the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) models.1, 2